FDA Inspection
Pfizer Healthcare India Private LimitedPfizer Healthcare India Private Limited – FDA Inspection, Sep 6, 2019
Record Details
This FDA Inspection record concerns Pfizer Healthcare India Private Limited, with an inspection on September 6, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d661c7f5-6120-4820-af7a-3caf6f60c2b8
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1106244
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
Other FDA inspections of Pfizer Healthcare India Private Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 10, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| October 18, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 17, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pfizer Healthcare India Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.